Table 4.

Stratified analysis.

Test	Baseline		12 months		Test statistics
	Median	IQR	Median	IQR	Z	p	r
(A) Not abused patients
Symptom Checklist-90 (SCL-90)
SOM	1	1.50	0.53	1	−2.90	<0.01	−0.53
OC	1.3	2	0.80	1.1	−2.05	<0.05	−0.37
IS	0.56	2	0.50	1	−1.36	0.173	−0.25
DEP	1.08	1.46	0.46	1.34	−1.50	0.133	−0.27
ANX	0.80	2.2	0.40	0.9	−1.61	0.107	−0.29
HOS	0.50	0.99	0.20	1	−1.57	0.117	−0.29
PHOB	0.57	1.14	0	0.32	−2.20	<0.05	−0.40
PAR	0.83	1.17	0.44	1.40	−1.34	0.182	−0.24
PSY	0.40	1.2	0.20	0.4	−1.45	0.142	−0.26
GSI	0.84	1.41	0.40	0.72	−2.10	<0.05	−0.38
SLEEP	0.71	2	0.76	0.81	−1.39	0.164	−0.25
Eating Disorder Inventory-3 (EDI-3)
DT	1.71	3	0.86	1.67	−1.48	0.140	−0.27
B	0.87	1.38	0.34	1.11	−0.98	0.328	−0.18
BD	1.7	2.8	0.87	2.1	−1.37	0.172	−0.25
PA	1	2.01	1.54	1.10	−0.51	0.609	−0.09
LSE	1.66	2	1.30	1	−0.51	0.615	−0.09
II	1.71	1.86	1.71	0.90	−0.82	0.410	−0.15
IA	1.28	1.86	1.42	0.57	−1.04	0.300	−0.19
ID	1.63	2	0.88	1.42	−1.99	<0.05	−0.36
ED	1.25	1	0.70	0.75	−1.50	0.132	−0.27
P	1.16	1	1.33	1	−0.04	0.972	−0.01
A	1.42	1.57	1	1.09	−1.76	0.078	−0.32
MF	2	1.25	1.4	1.70	−1.33	0.184	−0.24
Barratt Impulsiveness Scale-11 (BIS-11)
A	11	4	11	4	−0.07	0.944	−0.01
IC	5	4	5	2	−1.21	0.227	−0.22
M	11	4	13	5	−1.48	0.138	−0.27
P	6	3	6	1	−0.04	0.972	−0.01
SF	14	5	12	2	−0.28	0.776	−0.05
CC	11	4	12	6	−1.03	0.304	−0.19
IA	17	7	15	7	−0.60	0.550	−0.11
IM	17	3	18	4	−1.80	0.072	−0.33
Inon Plan	24	4	24	6	−0.50	0.614	−0.09
Tot Bis11	58	10	58	8	−0.19	0.850	−0.03
DES	10.71	17.93	5.71	6.4	−2.50	<0.05	−0.46
GAF	51	11	61	9	−3.09	<0.01	−0.56
(B) Abused patients
SCL-90
SOM	1.50	1.41	1.02	1.1	−0.71	0.48	−0.15
OC	2	1.7	1.90	1.7	−0.58	0.56	−0.12
IS	1.78	2.33	1	2.45	−0.85	0.40	−0.18
DEP	1.69	1.92	1.2	1.92	−0.27	0.79	−0.06
ANX	1.2	2	0.90	1.4	−1.75	0.08	−0.37
HOS	1.33	1	1.67	2	−0.47	0.64	−0.10
PHOB	0.57	2.42	0.42	0.71	−1.87	0.06	−0.40
PAR	1.68	2.66	1.54	2.50	−0.42	0.68	−0.09
PSY	0.80	1.8	0.70	1.6	−2.25	0.02	−0.48
GSI	1.41	1.75	1.19	1.63	−1.16	0.25	−0.25
SLEEP	1.57	1.43	171	1.29	−1.72	0.09	−0.37
EDI-3
DT	1.29	2	1.14	2.43	−0.97	0.33	−0.21
B	0.63	2.62	1	1	−0.9	0.93	−0.19
BD	2.60	1.7	1.7	2.9	−1.28	0.20	−0.27
PA	2	1.14	1.28	1.66	−1.02	0.31	−0.22
LSE	2.16	2	2	1	−1.82	0.07	−0.39
II	2.14	1.57	1.14	1.42	−0.66	0.51	−0.14
IA	2.14	1.43	1.28	0.71	−1.48	0.14	−0.31
ID	1.51	2	1.12	1.63	−0.61	0.54	−0.13
ED	1.75	1	1.35	1.88	−1.60	0.11	−0.34
P	1.33	2	1	1	−0.15	0.88	−0.03
A	0.86	1.29	0.96	1.72	−1.36	0.17	−0.29
MF	1.50	1.88	1.25	0.32	−0.46	0.65	−0.10
BIS-11
A	12	4	13	3	−0.14	0.88	−0.03
IC	6	2	4	2	−1.90	0.06	−0.40
M	18	6	15	6	−1.21	0.23	−0.26
P	7	4	8	3	−0.43	0.67	−0.09
SF	18	4	19	5	−0.27	0.79	−0.06
CC	15	3	14	8	−0.51	0.61	−0.11
IA	19	4	17	4	−1.89	0.06	−0.40
IM	24	7	23	5	−0.81	0.42	−0.17
Inon Plan	33	5	33	3	−0.05	0.96	−0.01
Tot Bis11	74	12	70	10	−1.36	0.17	−0.29
DES	12.5	33.58	13.57	21.8	−1.29	0.20	−0.27
GAF	50	10	61	29	−2.53	0.011	−0.54

Bold font indicates the test abbreviations and significant results.